Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.38
Bid: 52.38
Ask: 52.40
Change: 1.18 (2.30%)
Spread: 0.02 (0.038%)
Open: 51.12
High: 52.60
Low: 51.08
Prev. Close: 51.20
LLOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Tender Offer for Certain Perpetual Notes

23 Jun 2016 12:11

RNS Number : 0966C
Lloyds Banking Group PLC
23 June 2016
 

 

 

 

 

 

 

 

23 June 2016

Lloyds Banking Group plc ANNOUNCES RESULTS OF TENDER OFFER FOR CERTAIN PERPETUAL NOTES

Lloyds Banking Group plc ('LBG') today announced the final results of its previously announced U.S. dollar cash tender offer (the 'Offer') for any and all of certain series of outstanding perpetual notes (the 'Notes') issued by Lloyds Bank plc and Bank of Scotland plc (formerly The Governor and Company of the Bank of Scotland). The Offer was made on the terms and subject to the conditions set forth in the Offer to Purchase dated 16 June 2016 (the 'Offer to Purchase'). Capitalised terms not otherwise defined in this announcement have the same meaning as in the Offer to Purchase.

 

Based on information provided by the Tender Agent, $629,760,000 in aggregate principal amount of the Notes listed in the table below were validly tendered and not validly withdrawn by 5.00pm, New York City time, on 22 June 2016 (the 'Expiration Deadline'), as more fully set forth below. LBG has accepted all Notes that were validly tendered and not validly withdrawn prior to the Expiration Deadline. The Any and All Settlement Date is expected to be 24 June 2016. No notes were tendered using the guaranteed delivery procedures.

 

The table below sets forth, among other things, the principal amount of each series of Notes validly tendered and not validly withdrawn at or prior to the Expiration Deadline:

 

 

Notes

Issuer

ISIN

Purchase Price1

Aggregate Principal Amount Tendered

Primary Capital Undated Floating Rate Notes(Series 1)

 

Lloyds Bank plc

GB0005224307

$650

$138,160,000

Primary Capital Undated Floating Rate Notes(Series 2)

 

Lloyds Bank plc

GB0005205751

$650

$150,520,000

Primary Capital Undated Floating Rate Notes(Series 3)

 

Lloyds Bank plc

GB0005232391

$650

$193,460,000

Undated Floating Rate Primary Capital Notes

 

Bank of Scotland plc

GB0000765403

$650

$147,620,000

1 Per $1,000 in principal amount of Notes accepted for purchase.

 

 

- END -

 

Lucid Issuer Services Limited acted as tender agent for the Offer. BNP Paribas Securities Corp., Citigroup Global Markets Limited and Lloyds Bank plc acted as Dealer Managers for the Offer. Questions regarding the Offer should be directed to BNP Paribas Securities Corp., Liability Management Group at +1 (212) 841-3059 (U.S. collect), +1 (888) 210-4358 (U.S. toll free), +44 (0) 20 7595 8668 (Europe); Citigroup Global Markets Limited, Liability Management Group at +1 (212) 723-6106 (U.S. collect), +1 (800) 558-3745 (U.S. toll free), +44 (0) 20 7986 8969 (Europe); Lloyds Bank plc, Liability Management Group at +1 (212) 827-3105 (U.S. collect), +1 (855) 400-6511 (U.S. toll free), +44 (0) 20 7158 2720 (Europe).

 

 

 

For further information:

 

Investor Relations

Mike Butters +44 (0) 20 7356 1187

Director of Investor Relations

Email: mike.butters@finance.lloydsbanking.com 

 

 

 

 

 

 

 

FORWARD LOOKING STATEMENTS

This document contains certain forward looking statements with respect to the business, strategy and plans of Lloyds Banking Group and its current goals and expectations relating to its future financial condition and performance. Statements that are not historical facts, including statements about Lloyds Banking Group's or its directors' and/or management's beliefs and expectations, are forward looking statements. By their nature, forward looking statements involve risk and uncertainty because they relate to events and depend upon circumstances that will or may occur in the future. Factors that could cause actual business, strategy, plans and/or results (including but not limited to the payment of dividends) to differ materially from the plans, objectives, expectations, estimates and intentions expressed in such forward looking statements made by the Group or on its behalf include, but are not limited to: general economic and business conditions in the UK and internationally; market related trends and developments; fluctuations in exchange rates, stock markets and currencies; the ability to access sufficient sources of capital, liquidity and funding when required; changes to the Group's credit ratings; the ability to derive cost savings; changing customer behaviour including consumer spending, saving and borrowing habits; changes to borrower or counterparty credit quality; instability in the global financial markets, including Eurozone instability, the potential for one or more countries to exit the Eurozone or European Union (EU) (including the UK as a result of a referendum on its EU membership) and the impact of any sovereign credit rating downgrade or other sovereign financial issues; technological changes and risks to cyber security; natural, pandemic and other disasters, adverse weather and similar contingencies outside the Group's control; inadequate or failed internal or external processes or systems; acts of war, other acts of hostility, terrorist acts and responses to those acts, geopolitical, pandemic or other such events; changes in laws, regulations, accounting standards or taxation, including as a result of further Scottish devolution; changes to regulatory capital or liquidity requirements and similar contingencies outside the Group's control; the policies, decisions and actions of governmental or regulatory authorities or courts in the UK, the EU, the US or elsewhere including the implementation and interpretation of key legislation and regulation; the ability to attract and retain senior management and other employees; requirements or limitations imposed on the Group as a result of HM Treasury's investment in the Group; actions or omissions by the Group's directors, management or employees including industrial action; changes to the Group's post-retirement defined benefit scheme obligations; the provision of banking operations services to TSB Banking Group plc; the extent of any future impairment charges or write-downs caused by, but not limited to, depressed asset valuations, market disruptions and illiquid markets; the value and effectiveness of any credit protection purchased by the Group; the inability to hedge certain risks economically; the adequacy of loss reserves; the actions of competitors, including non-bank financial services and lending companies; and exposure to regulatory or competition scrutiny, legal, regulatory or competition proceedings, investigations or complaints. Please refer to the latest Annual Report on Form 20-F filed with the US Securities and Exchange Commission for a discussion of certain factors together with examples of forward looking statements. Except as required by any applicable law or regulation, the forward looking statements contained in this document are made as of today's date, and Lloyds Banking Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward looking statements. The information, statements and opinions contained in this document do not constitute a public offer under any applicable law or an offer to sell any securities or financial instruments or any advice or recommendation with respect to such securities or financial instruments.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TENFJMMTMBATBLF
Date   Source Headline
25th Apr 20245:50 pmRNSTransaction in Own Shares
25th Apr 20241:14 pmRNSPublication of Suppl.Prospcts
24th Apr 20246:21 pmRNSTransaction in Own Shares
24th Apr 20242:37 pmRNSPublication of Suppl.Prospcts
24th Apr 202412:29 pmRNSPublication of Suppl.Prospcts
24th Apr 202411:03 amRNS2024 Q1 Interim Management Statement
24th Apr 20247:00 amRNS2024 Q1 Interim Management Statement
23rd Apr 20246:05 pmRNSTransaction in Own Shares
22nd Apr 20245:55 pmRNSTransaction in Own Shares
19th Apr 20245:41 pmRNSTransaction in Own Shares
18th Apr 20246:01 pmRNSTransaction in Own Shares
17th Apr 20246:10 pmRNSTransaction in Own Shares
16th Apr 20246:11 pmRNSTransaction in Own Shares
15th Apr 20245:59 pmRNSTransaction in Own Shares
12th Apr 20245:57 pmRNSTransaction in Own Shares
11th Apr 20245:37 pmRNSTransaction in Own Shares
11th Apr 20242:00 pmRNSDirector/PDMR Shareholding
10th Apr 20246:02 pmRNSTransaction in Own Shares
9th Apr 20246:07 pmRNSTransaction in Own Shares
8th Apr 20246:02 pmRNSTransaction in Own Shares
4th Apr 20246:05 pmRNSTransaction in Own Shares
4th Apr 202410:10 amRNSPublication of Final Terms
3rd Apr 20246:01 pmRNSTransaction in Own Shares
2nd Apr 20245:56 pmRNSTransaction in Own Shares
28th Mar 20245:46 pmRNSTransaction in Own Shares
28th Mar 20245:39 pmRNSTotal Voting Rights
28th Mar 20245:24 pmRNSPublication of a Prospectus
28th Mar 20249:30 amRNSBlock Listing of Shares
27th Mar 20246:10 pmRNSTransaction in Own Shares
26th Mar 20245:53 pmRNSTransaction in Own Shares
26th Mar 20242:00 pmRNSDirector/PDMR Shareholding
25th Mar 20245:34 pmRNSTransaction in Own Shares
22nd Mar 20246:14 pmRNSPublication of a Prospectus
21st Mar 20246:13 pmRNSTransaction in Own Shares
21st Mar 20244:28 pmRNSNotice of AGM
20th Mar 20246:16 pmRNSTransaction in Own Shares
19th Mar 20246:18 pmRNSTransaction in Own Shares
18th Mar 20246:19 pmRNSTransaction in Own Shares
15th Mar 20246:05 pmRNSTransaction in Own Shares
15th Mar 20242:00 pmRNSDirector/PDMR Shareholding
14th Mar 20245:58 pmRNSTransaction in Own Shares
13th Mar 20246:23 pmRNSTransaction in Own Shares
13th Mar 20243:00 pmRNSDirector/PDMR Shareholding
12th Mar 20246:16 pmRNSTransaction in Own Shares
11th Mar 20246:16 pmRNSTransaction in Own Shares
8th Mar 20245:33 pmRNSTransaction in Own Shares
8th Mar 20241:30 pmRNSDirector/PDMR Shareholding
7th Mar 20246:06 pmRNSTransaction in Own Shares
7th Mar 20242:29 pmRNSDirector/PDMR Shareholding
6th Mar 20246:08 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.